Skip NavigationSkip to Content
Return Return to Search Results

Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus

  1. Author:
    Stergiopoulou, T.
    Meletiadis, J.
    Sein, T.
    Papaioannidou, P.
    Tsiouris, I.
    Roilides, E.
    Walsh, T. J.

  2. Author Address

    Stergiopoulou, Theodouli, Meletiadis, Joseph, Sein, Tin, Roilides, Emmanuel, Walsh, Thomas J.] NCI, Pediat Oncol Branch, NIH, Immunocompromised Host Sect, Bethesda, MD 20892 USA. [Sein, Tin] SAIC Frederick Inc, Frederick, MD 21702 USA. [Stergiopoulou, Theodouli, Papaioannidou, Paraskevi] Aristotle Univ Thessaloniki, Fac Med, Dept Pharmacol, GR-54006 Thessaloniki, Greece. [Tsiouris, Ioannis, Roilides, Emmanuel] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Pediat 3, GR-54006 Thessaloniki, Greece.
    1. Year: 2008
  2. Journal: Antimicrobial Agents and Chemotherapy
    1. 52
    2. 6
    3. Pages: 2196-2204
  4. Type of Article: Article
  1. Abstract:

    Patients suffering from invasive mycoses often receive concomitant antifungal therapy and antibacterial agents. Assessment of pharmacodynamic interactions between antifungal and antibacterial agents is complicated by the absence of a common antifungal end point for both agents. Ciprofloxacin has no intrinsic antifungal activity but may interact with antifungal agents, since it inhibits DNA gyrase (topoisomerase II), which is abundant in fungi. We therefore employed isobolographic analysis adapted to incorporate a nonactive agent in order to analyze the potential in vitro interaction between the fluoroquinolone ciprofloxacin and several representative antifungal agents against Candida albicans and Aspergillus fumigatus strains by using a microdilution checkerboard technique. In agreement with earlier in vitro studies, conventional fractional inhibitory concentration index analysis was unable to detect interactions between ciprofloxacin and antifungal agents. However, isobolographic analysis revealed significant pharmacodynamic interactions between antifungal agents and ciprofloxacin against C. albicans and A. fumigatus strains. Amphotericin B demonstrated concentration-dependent interactions for both species, with synergy (interaction indices, 0.14 to 0.81) observed at ciprofloxacin concentrations of <10.64 mu g/ml. Synergy (interaction indices, 0.10 to 0.86) was also found for voriconazole and caspofungin against A. fumigatus. Isobolographic analysis may help to elucidate the pharmacodynamic interactions between antifungal and non-antifungal agents and to develop better management strategies against invasive candidiasis and aspergillosis.

    See More

  1. Keywords:

External Sources

  1. PMID: 18299413

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel